Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151 INR | +5.37% | +6.19% | +8.79% |
Sales 2024 * | 81.13B 972M | Sales 2025 * | 92.97B 1.11B | Capitalization | 200B 2.4B |
---|---|---|---|---|---|
Net income 2024 * | 1.18B 14.12M | Net income 2025 * | 5.06B 60.66M | EV / Sales 2024 * | 2.88 x |
Net Debt 2024 * | 33.7B 404M | Net Debt 2025 * | 27.93B 335M | EV / Sales 2025 * | 2.45 x |
P/E ratio 2024 * |
201
x | P/E ratio 2025 * |
39.5
x | Employees | 6,295 |
Yield 2024 * |
0.13% | Yield 2025 * |
0.33% | Free-Float | 26.56% |
Latest transcript on Piramal Pharma Limited
1 day | +5.37% | ||
1 week | +6.19% | ||
Current month | +5.15% | ||
1 month | +10.98% | ||
3 months | +9.73% | ||
6 months | +44.34% | ||
Current year | +8.79% |
Managers | Title | Age | Since |
---|---|---|---|
Peter DeYoung
CEO | Chief Executive Officer | 46 | 04/20/04 |
Vivek Valsaraj
PSD | President | 51 | 10/20/10 |
Vinay Agrawal
COO | Chief Operating Officer | 60 | 05/20/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 43 | 04/21/04 | |
Neeraj Bharadwaj
BRD | Director/Board Member | 55 | - |
Director/Board Member | 76 | 09/21/09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 7 M€ | +3.48% | - | |
0.00% | 117 M€ | +2.11% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 151 | +5.37% | 26,693,210 |
02/24/02 | 143.4 | -0.21% | 1,306,760 |
30/24/30 | 143.6 | +0.24% | 3,126,412 |
29/24/29 | 143.3 | +0.74% | 3,241,028 |
26/24/26 | 142.2 | +0.21% | 2,286,342 |
Delayed Quote NSE India S.E., May 03, 2024 at 05:13 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.79% | 2.4B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- PPLPHARMA Stock